The use of biomarkers in aiding the diagnosis and treatment of cardiac disorders is increasing globally as they offer the opportunity to improve the clinical assessment of coronary diseases while reducing costs. The laboratory plays a critical role in the selection and analysis of such biomarkers highlighting the need for clinicians and the laboratory to work in closer harmony to enhance patient care and improve the quality and reliability of these tests.

This conference will discuss best practices for collaboration between cardiologists and the laboratory in relation to the most recent and prevalent biomarkers. Major analytic and clinical issues will be addressed, along with advice on the most recent regulations surrounding the use of cardiac biomarkers in practice. Cardiovascular and laboratory professionals will not only be equipped with world-class knowledge helping to improve patient care, but partake in networking with thousands of medical laboratory and clinical specialists.

This is the only focused cardiac marker interpretation conference in the region led by clinicians and laboratory professionals which will discuss about developments in current and new markers for acute coronary syndrome, atherosclerosis, chronic heart failure and non-cardiac conditions. 

What are the main topics covered in this event?

  • High sensitivity assays
  • Biochemical markers of acute coronary syndrome
  • Biomarkers for atherosclerosis and metabolic syndrome
  • Biomarkers for chronic heart failure

Benefits of Attendance

  • Evaluate the role of cardiac markers in acute coronary syndrome and chronic heart failure to reduce cardiovascular related mortality
  • Discuss high sensitivity assays and how to use them to improve the accuracy and reliability of diagnosis and discharge decisions
  • Assess the most recent biomarkers for atherosclerosis and metabolic syndrome to improve the quality of clinical decision making

Activity Director: Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Lab Med Institute, Cleveland Clinic, Cleveland, Ohio, USA

Local Chair: Professor Abdullah Shehab, President Emirates Cardiac Society; Professor of Cardiovascular Medicine, Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE